As of Mar 19
| +0.91 / +0.63%|
The 12 analysts offering 12-month price forecasts for Charles River Laboratories International Inc have a median target of 151.00, with a high estimate of 165.00 and a low estimate of 110.00. The median estimate represents a +3.56% increase from the last price of 145.81.
The current consensus among 16 polled investment analysts is to Buy stock in Charles River Laboratories International Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.